Health Sciences

Researchers at the Perelman School of Medicine at the University of Pennsylvania and other institutions have uncovered a site of genetic variation that identified which patients with Parkinson’s disease are more likely to have tremors versus difficulty with balance and walking.

A national research study to focus on diet as a tool for managing Crohn’s disease symptoms, led by James Lewis, MD, MSCE, a professor of Medicine and Epidemiology at the Perelman School of Medicine at the University of Pennsylvania, on behalf of the Crohn’s & Colitis Foundation of America (CCFA), has been approved to receive a $2.5 million funding award by the Patient-Cent

Researchers at the Perelman School of Medicine at the University of Pennsylvania and other institutions have uncovered a site of genetic variation that identified which patients with Parkinson’s disease are more likely to have tremors versus difficulty with balance and walking.

New preclinical research provides support to a drug that has been repurposed to possibly treat a rare and extremely disabling genetic bone disease, particularly in children.

Two researchers from the Perelman School of Medicine at the University of Pennsylvania are among the recipients of the 2016 Clinical Research Achievement Award. The researchers recognized include Carl H.

How the human brain processes the words we hear and constructs complex concepts is still somewhat of a mystery to the neuroscience community.

April is National Oral Cancer Awareness Month and University of Pennsylvania School of Dental Medicine students teamed with students from Temple University to bring attention to the disease and the importance of early detection through the annual Philadelphia Oral Cancer Walk and 5K on April 2.

When Eve Higginbotham took on the role of inaugural vice dean to establish the Office for Inclusion and Diversity (OID) at the Perelman School of Medicine in 2013, her star

The Fels Policy Research Initiative in the School of Arts & Sciences at the University of Pennsylvania has announced five inaugural collaborative grants for as much as $15,000 each, designed to further interdisciplinary partnerships. 

The once-a-month drug naltrexone was more effective at preventing drug relapse in ex-prisoners addicted to heroin and other opioids compared to the usual treatment modalities, including counseling and community treatment programs, according to results from a multisite, randomized trial led by researchers at the Center for Studies of Add